Ticker	Volume	Price	Price Delta
DJIA	15,112.20	-206.04	-1.35%
S&P 500	1,628.93	-22.88	-1.39%
Nasdaq	3,443.20	-38.98	-1.12%

Ticker

Volume

Price

Price Delta

DJIA

15,112.20

-206.04

-1.35%

S&P 500

1,628.93

-22.88

-1.39%

Nasdaq

3,443.20

-38.98

-1.12%

Ticker	Volume	Price	Price Delta
STOXX 50	2,683.98	-16.95	-0.63%
FTSE 100	6,348.82	-25.39	-0.40%
DAX	8,197.08	-32.43	-0.39%

Ticker

Volume

Price

Price Delta

STOXX 50

2,683.98

-16.95

-0.63%

FTSE 100

6,348.82

-25.39

-0.40%

DAX

8,197.08

-32.43

-0.39%

Ticker	Volume	Price	Price Delta
Nikkei	13,068.60	-176.61	-1.33%
Hang Seng	20,986.90	-238.99	-1.13%
S&P/ASX 200	4,803.10	-58.28	-1.20%

Ticker

Volume

Price

Price Delta

Nikkei

13,068.60

-176.61

-1.33%

Hang Seng

20,986.90

-238.99

-1.13%

S&P/ASX 200

4,803.10

-58.28

-1.20%

D-Pharm Climbs Most in Two Weeks on Deal to Acquire Thrombotech

By David Wainer - 2012-05-07T12:28:01Z

D-Pharm Ltd. (DPRM) rose the most in more than two weeks after the biopharmaceutical company reached an initial agreement to buy Thrombotech Ltd., which is developing a peptide that improves the efficiency of stroke medication.

The shares of the Nes Ziona, Israel-based company rose 8 percent, the biggest intraday advance since April 19, to 1.011 shekels at 3:11 p.m. in Tel Aviv.

To contact the reporter on this story: David Wainer in Tel Aviv at dwainer3@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.